vancomycin has been researched along with cephalexin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholomew, PT; Brittelli, DR; Eberly, VS; Eustice, DC; Forbes, M; Gregory, WA; McRipley, RJ; Slee, AM; Wang, CL; Wuonola, MA | 1 |
| Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Duval, V; Glupczynski, Y; Joris, B; Lemaire, S; Tulkens, PM; Van Bambeke, F | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Durack, DT; Pelletier, LL; Petersdorf, RG | 1 |
| Aronoff, GR; Bunke, CM; Luft, FC | 1 |
| Fraser, GM; Inbar-Yanai, I; Niv, Y | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Feder, HM | 1 |
| Hu, V; Larkin, G; Muir, G; Stanford, M; Zaidi, F | 1 |
| Agrawal, A; Chen, R; Ducheyne, P; Guo, S; Qu, H | 1 |
| Huang, WE; Kong, L; Li, B; Li, H; Wang, Y; Xu, J; Zheng, C | 1 |
| Abbas Abood, I; Hamdi Abdulkareem, M; Munis Dakheel, M | 1 |
1 review(s) available for vancomycin and cephalexin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for vancomycin and cephalexin
| Article | Year |
|---|---|
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" group.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Oxazoles; Structure-Activity Relationship | 1989 |
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cell Line; Cephalosporins; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Keratinocytes; Macrophages; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phagocytosis; Ribonucleoproteins; Saccharomyces cerevisiae Proteins; Staphylococcus aureus | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin | 1975 |
Pharmacokinetics of common antibiotics used in continuous ambulatory peritoneal dialysis.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalexin; Humans; Kinetics; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Tobramycin; Vancomycin | 1983 |
Pseudomembranous colitis in a patient with a colostomy.
Topics: Cephalexin; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Methicillin-resistant Staphylococcus aureus infections in 2 pediatric outpatients.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephalosporins; Child; Clindamycin; Community-Acquired Infections; Drainage; Female; Hospitalization; Humans; Infant; Methicillin Resistance; Neck; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Failure; Vancomycin | 2000 |
Bilateral endogenous endophthalmitis after holmium laser lithotripsy.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Ceftazidime; Ceftriaxone; Cephalexin; Drug Therapy, Combination; Endophthalmitis; Female; Gentamicins; Holmium; Humans; Lithotripsy, Laser; Middle Aged; Pseudomonas Infections; Ureteral Calculi; Urinary Tract Infections; Vancomycin | 2007 |
Controlled release of small molecules from silica xerogel with limited nanoporosity.
Topics: Anti-Bacterial Agents; Bupivacaine; Cephalexin; Gels; Hydrolysis; Nanotechnology; Silicon Dioxide; Vancomycin | 2013 |
Raman-activated sorting of antibiotic-resistant bacteria in human gut microbiota.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cephalexin; Drug Resistance, Bacterial; Gastrointestinal Microbiome; Humans; Metagenome; Metagenomics; Nonlinear Optical Microscopy; Sequence Analysis, DNA; Tetracycline; Thiamphenicol; Vancomycin | 2020 |
Antimicrobial Resistance of Tannin Extract against
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalexin; Clindamycin; Drug Resistance, Bacterial; Escherichia coli; Humans; Kanamycin; Plant Extracts; Sheep; Tannins; Tetracyclines; Vancomycin | 2022 |